tiprankstipranks
Trending News
More News >
Helix BioPharma (TSE:HBP)
TSX:HBP
Canadian Market

Helix BioPharma (HBP) Cash flow

Compare
30 Followers

Helix BioPharma Cash Flow

TSE:HBP's free cash flow for Q4 2025 was C$-649.00K. For the 2025 fiscal year, TSE:HBP's free cash flow was decreased by C$1.40M and operating cash flow was C$-649.00K. See a summary of the company’s cash flow.
Cash Flow
Dec 25Dec 24Dec 23Dec 22Dec 21
Operating Cash Flow
C$ -3.83MC$ -5.22MC$ -5.53MC$ -6.51MC$ -9.30M
Investing Cash Flow
C$ 17.00KC$ -14.00KC$ -5.00KC$ 0.00C$ 2.02M
Financing Cash Flow
C$ 2.80MC$ 5.51MC$ 3.09MC$ 6.21MC$ 6.56M
End Cash Position
C$ 65.00KC$ 1.08MC$ 808.00KC$ 3.25MC$ 3.56M
Free Cash Flow
C$ -3.83MC$ -5.23MC$ -5.54MC$ -6.51MC$ -9.30M
Currency in CAD

Helix BioPharma Cash Flow